Hui‐Kuan Lin

15.4k citations
119 papers · 10.8k · 4 hit papers · h-index 53

Impact in

    • Cancer-related molecular mechanisms research
    • Ubiquitin and proteasome pathways
    • PI3K/AKT/mTOR signaling in cancer
    • Epigenetics and DNA Methylation
    • RNA modifications and cancer

Papers in

    • Ubiquitin and proteasome pathways 26
    • PI3K/AKT/mTOR signaling in cancer 15
    • Epigenetics and DNA Methylation 12
    • Metabolism, Diabetes, and Cancer 11
    • Histone Deacetylase Inhibitors Research 9
    • Cancer-related Molecular Pathways 22

Hui‐Kuan Lin

117 papers receiving 10.7k citations

Hui‐Kuan Lin's Hit Papers

CD36-mediated endocytosis of proteolysis-targeting chimeras 2025 · 25 citations
250+7+14Years since publication50010001.5k

Peers

Hui‐Kuan Lin
Comparison fields: 5 of 130
  • Cancer Research 2.1k
  • Molecular Biology 7.1k
  • Oncology 2.0k
  • Pulmonary and Respiratory Medicine 1.6k
  • Cell Biology 890
Replace Alfonso Bellacosa with:
Alfonso Bellacosa United States
Edward V. Prochownik United States
David Stokoe United States
James Brugarolas United States
Ygal Haupt Australia
Joyce M. Slingerland United States
Linda Z. Penn Canada
Antonio Di Cristofano United States
Yataro Daigo Japan
Timothy J. McDonnell United States
Hui‐Kuan Lin relative to Alfonso Bellacosa United States Alfonso Bellacosa's profile →
Citations per field
00.5×2.9×
Alfonso Bellacosa · 1×
Citations per year

Countries citing papers authored by Hui‐Kuan Lin

Since Specialization
Citations

This map shows the geographic impact of Hui‐Kuan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Kuan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Kuan Lin more than expected).

Fields of papers citing papers by Hui‐Kuan Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Kuan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Kuan Lin. The network helps show where Hui‐Kuan Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Hui‐Kuan Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hui‐Kuan Lin Line = papers co-authored together Hui‐Kuan Lin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Hit paper breakdown →
20051545
2
The E3 Ligase TRAF6 Regulates Akt Ubiquitination and Activation
Hit paper breakdown →
2009503
3 1999459
4 2006430
5
Circular RNAs in cancer: novel insights into origins, properties, functions and implications.
2015371
6 2012355
7 2010349
8 2012347
9 2001329
10 2013321
11 2004258
12 2016249
13 2014189
14 2012185
15 2005172
16 2021165
17 2003149
18 2019147
19 2003142
20
NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistance
Hit paper breakdown →
2023139

About Hui‐Kuan Lin

Hui‐Kuan Lin is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Hematology, having authored 119 papers that have together received 10.8k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (26 papers), Cancer-related Molecular Pathways (22 papers), PI3K/AKT/mTOR signaling in cancer (15 papers), Prostate Cancer Treatment and Research (14 papers), Epigenetics and DNA Methylation (12 papers), Metabolism, Diabetes, and Cancer (11 papers), Histone Deacetylase Inhibitors Research (9 papers) and Cancer, Hypoxia, and Metabolism (9 papers). The work is most often cited by research in Cancer Research (2.1k citations), Molecular Biology (7.1k citations), Oncology (2.0k citations), Pulmonary and Respiratory Medicine (1.6k citations) and Cell Biology (890 citations). Hui‐Kuan Lin has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Pier Paolo Pandolfi, Chawnshang Chang, Hong‐Yo Kang, Shuyuan Yeh, Chia‐Hsin Chan, Jason A. Koutcher, William L. Gerald, Zhenbang Chen, Lloyd C. Trotman and David R. Shaffer. Their work appears in journals such as Blood, Cancer Research, Oncogene, Journal of Biological Chemistry and Nature Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact